Literature DB >> 1613556

Astrocyte precursors in neonatal rat spinal cord cultures.

J Fok-Seang1, R H Miller.   

Abstract

Cultures of newborn rat spinal cord contain multiple types of astrocytes. By using a combination of cultures enriched for glial precursors and clonal analysis, we have identified a particular astrocyte precursor that gives rise to morphologically distinct classes of astrocytes. This astrocyte precursor labels with the monoclonal antibody A2B5, is highly migratory, proliferates in response to serum and platelet-derived growth factor, and differentiates into process-bearing astrocytes, many of which subsequently assume a "pancake"-shaped morphology. A2B5+ astrocyte precursors share antigenic and migratory characteristics with previously described O2A progenitor cells but differ in their response to regulatory factors, including serum and coculture with type 1 astrocytes. More importantly, these astrocyte precursors do not give rise to oligodendrocytes. In their proliferative response to serum and their capacity to differentiate into astrocytes, these glial precursors resemble type 1 astrocyte precursors from optic nerve. However, unlike type 1 astrocyte precursors, these cells are A2B5+, highly migratory, and do not give rise to fibroblast-like astrocytes. Neonatal rat spinal cord cultures contain approximately twice the number of the A2B5+ astrocyte precursors than O2A progenitor cells. By contrast, the majority of A2B5+ cells in postnatal day 7 optic nerve cultures are O2A progenitors. The presence of large numbers of A2B5+ astrocyte precursors in rat spinal cord cultures may reflect the more complex cytoarchitecture of the spinal cord compared to the optic nerve.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613556      PMCID: PMC6575843     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function.

Authors:  Ninel Gregori; Christoph Pröschel; Mark Noble; Margot Mayer-Pröschel
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  A tripotential glial precursor cell is present in the developing spinal cord.

Authors:  M S Rao; M Noble; M Mayer-Pröschel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 3.  Origin of Oligodendrocytes in the Vertebrate Optic Nerve: A Review.

Authors:  Katsuhiko Ono; Yukie Hirahara; Hitoshi Gotoh; Tadashi Nomura; Hirohide Takebayashi; Hisao Yamada; Kazuhiro Ikenaka
Journal:  Neurochem Res       Date:  2017-10-04       Impact factor: 3.996

4.  Induction of astrocyte differentiation by endothelial cells.

Authors:  H Mi; H Haeberle; B A Barres
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

5.  Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination.

Authors:  Craig S Moore; Richard Milner; Akiko Nishiyama; Ricardo F Frausto; David R Serwanski; Roberto R Pagarigan; J Lindsay Whitton; Robert H Miller; Stephen J Crocker
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

6.  Comparison of expression and proliferative effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors on human astrocytoma cell lines.

Authors:  Tomoya Nakamachi; Kouichi Sugiyama; Jun Watanabe; Nori Imai; Nobuyuki Kagami; Motohide Hori; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2014-08-06       Impact factor: 3.444

7.  Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins.

Authors:  H J Willison; G Paterson; J Veitch; G Inglis; S C Barnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

8.  Purification and characterization of astrocyte precursor cells in the developing rat optic nerve.

Authors:  H Mi; B A Barres
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.